Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 3
1948 2
1949 1
1950 1
1951 4
1952 1
1953 2
1954 5
1956 3
1958 2
1959 4
1960 9
1961 10
1962 11
1963 49
1964 97
1965 62
1966 58
1967 91
1968 113
1969 145
1970 156
1971 170
1972 180
1973 201
1974 221
1975 184
1976 204
1977 158
1978 191
1979 205
1980 251
1981 214
1982 218
1983 262
1984 293
1985 320
1986 316
1987 359
1988 359
1989 449
1990 472
1991 508
1992 563
1993 579
1994 654
1995 703
1996 776
1997 738
1998 744
1999 718
2000 703
2001 768
2002 768
2003 802
2004 838
2005 913
2006 1132
2007 1384
2008 1520
2009 1580
2010 1630
2011 1709
2012 1727
2013 1895
2014 1957
2015 2061
2016 2090
2017 2109
2018 2015
2019 2007
2020 2160
2021 2116
2022 1823
2023 1528
2024 1547
2025 780

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46,164 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Thrombosis in device"
Page 1
Device-Related Thrombosis in Continuous-Flow Left Ventricular Assist Device Support.
Doligalski CT, Jennings DL. Doligalski CT, et al. J Pharm Pract. 2016 Feb;29(1):58-66. doi: 10.1177/0897190015615894. Epub 2015 Nov 24. J Pharm Pract. 2016. PMID: 26602063 Review.
The most concerning of these complications to emerge is device-related thrombosis, which is associated with increased morbidity and mortality. ...This review seeks to summarize the current literature surrounding the pathophysiology, diagnosis, and management of t …
The most concerning of these complications to emerge is device-related thrombosis, which is associated with increased morbidit …
Unexpected abrupt increase in left ventricular assist device thrombosis.
Starling RC, Moazami N, Silvestry SC, Ewald G, Rogers JG, Milano CA, Rame JE, Acker MA, Blackstone EH, Ehrlinger J, Thuita L, Mountis MM, Soltesz EG, Lytle BW, Smedira NG. Starling RC, et al. N Engl J Med. 2014 Jan 2;370(1):33-40. doi: 10.1056/NEJMoa1313385. Epub 2013 Nov 27. N Engl J Med. 2014. PMID: 24283197 Free article.
BACKGROUND: We observed an apparent increase in the rate of device thrombosis among patients who received the HeartMate II left ventricular assist device, as compared with preapproval clinical-trial results and initial experience. ...RESULTS: A total of 72 pu …
BACKGROUND: We observed an apparent increase in the rate of device thrombosis among patients who received the HeartMate II lef …
Introducing the pro-coagulant contact system in the numerical assessment of device-related thrombosis.
Méndez Rojano R, Mendez S, Nicoud F. Méndez Rojano R, et al. Biomech Model Mechanobiol. 2018 Jun;17(3):815-826. doi: 10.1007/s10237-017-0994-3. Epub 2018 Jan 4. Biomech Model Mechanobiol. 2018. PMID: 29302840
Thrombosis is a major concern in blood-coated medical devices. Contact activation, which is the initial part of the coagulation cascade in device-related thrombosis, is not considered in current thrombus formation models. ...The biochemical/fluid model …
Thrombosis is a major concern in blood-coated medical devices. Contact activation, which is the initial part of the coagulatio …
Tortuosity-powered microfluidic device for assessment of thrombosis and antithrombotic therapy in whole blood.
Luna DJ, R Pandian NK, Mathur T, Bui J, Gadangi P, Kostousov VV, Hui SR, Teruya J, Jain A. Luna DJ, et al. Sci Rep. 2020 Apr 1;10(1):5742. doi: 10.1038/s41598-020-62768-4. Sci Rep. 2020. PMID: 32238835 Free PMC article.
However, current monitoring devices do not measure the effects of hemodynamic forces that contribute significantly to coagulation, platelet function and fibrin formation. ...Thus, this tortuosity activated microfluidic device could lead to a more quantitative and ra …
However, current monitoring devices do not measure the effects of hemodynamic forces that contribute significantly to coagulation, pl …
Platelet Adhesion and Activation in an ECMO Thrombosis-on-a-Chip Model.
Goh T, Gao L, Singh J, Totaro R, Carey R, Yang K, Cartwright B, Dennis M, Ju LA, Waterhouse A. Goh T, et al. Adv Sci (Weinh). 2024 Aug;11(30):e2401524. doi: 10.1002/advs.202401524. Epub 2024 May 17. Adv Sci (Weinh). 2024. PMID: 38757670 Free PMC article.
Medical device thrombosis is potentiated by the interplay between biomaterial properties, hemodynamic flow conditions and patient pathology, however, the contribution and importance of these factors are poorly understood because many in vitro models lack the capabil …
Medical device thrombosis is potentiated by the interplay between biomaterial properties, hemodynamic flow conditions and pati …
Left Ventricular Assist Device Thrombosis Is Associated With an Increase in the Systolic-to-Diastolic Velocity Ratio Measured at the Inflow and Outflow Cannulae.
Jain A, Rohrer B, Gebhardt B, Breeze JL, Quick JD, Couper G, Kiernan MS, Lawrence M, Cobey FC. Jain A, et al. J Cardiothorac Vasc Anesth. 2017 Apr;31(2):497-504. doi: 10.1053/j.jvca.2016.11.038. Epub 2016 Nov 24. J Cardiothorac Vasc Anesth. 2017. PMID: 28216204 Free PMC article.
OBJECTIVE: To determine whether the ratio of peak systolic-to-nadir diastolic velocity (S/D ratio) measured using Doppler at the left ventricular assist device (LVAD) inflow and outflow cannulae is associated with pump thrombosis and to determine whether there is an …
OBJECTIVE: To determine whether the ratio of peak systolic-to-nadir diastolic velocity (S/D ratio) measured using Doppler at the left ventri …
Device thrombosis and pre-clinical blood flow models for assessing antithrombogenic efficacy of drug-device combinations.
Sukavaneshvar S. Sukavaneshvar S. Adv Drug Deliv Rev. 2017 Mar;112:24-34. doi: 10.1016/j.addr.2016.07.009. Epub 2016 Aug 3. Adv Drug Deliv Rev. 2017. PMID: 27496706 Review.
However, balancing the risk of bleeding with the antithrombotic efficacy of these drugs continues to be a challenge, and surface modification of devices with these drug molecules to mitigate device thrombosis locally has been explored. ...Despite considerable …
However, balancing the risk of bleeding with the antithrombotic efficacy of these drugs continues to be a challenge, and surface modificatio …
Advancements in left ventricular assist devices to prevent pump thrombosis and blood coagulopathy.
Malone G, Abdelsayed G, Bligh F, Al Qattan F, Syed S, Varatharajullu P, Msellati A, Mwipatayi D, Azhar M, Malone A, Fatimi SH, Conway C, Hameed A. Malone G, et al. J Anat. 2023 Jan;242(1):29-49. doi: 10.1111/joa.13675. Epub 2022 Apr 20. J Anat. 2023. PMID: 35445389 Free PMC article. Review.
Mechanical circulatory support (MCS) devices, such as left ventricular assist devices (LVADs) are very useful in improving outcomes in patients with advanced-stage heart failure. ...This paper discusses the development of LVADs through landmark clinical trials in de …
Mechanical circulatory support (MCS) devices, such as left ventricular assist devices (LVADs) are very useful in improving out …
Computational analysis of thrombosis risk with variations in left ventricular assist device inflow cannula design in a multi-patient model.
Khamooshi M, Azimi M, Gregory SD. Khamooshi M, et al. Comput Methods Programs Biomed. 2023 Oct;240:107730. doi: 10.1016/j.cmpb.2023.107730. Epub 2023 Jul 26. Comput Methods Programs Biomed. 2023. PMID: 37531687 Free article.
BACKGROUND AND OBJECTIVES: Left ventricular assist devices (LVADs) are mechanical pumps used to support patients with end-stage heart failure. ...However, the design of the cannula can significantly impact LV hemodynamics and cause complications, including thrombosis …
BACKGROUND AND OBJECTIVES: Left ventricular assist devices (LVADs) are mechanical pumps used to support patients with end-stage heart …
Management of pump thrombosis in patients with left ventricular assist devices.
Stulak JM, Sharma S, Maltais S. Stulak JM, et al. Am J Cardiovasc Drugs. 2015 Apr;15(2):89-94. doi: 10.1007/s40256-014-0102-3. Am J Cardiovasc Drugs. 2015. PMID: 25567787 Review.
The gradual evolution of left ventricular assist device (LVAD) therapy has resulted in a durable option for patients as either a bridge to transplantation (BTT) or a destination therapy (DT). ...We review the current status of the field of mechanical circulatory support in …
The gradual evolution of left ventricular assist device (LVAD) therapy has resulted in a durable option for patients as either a brid …
46,164 results
You have reached the last available page of results. Please see the User Guide for more information.